As Evercore prepares to report fourth-quarter results, analysts anticipate steady revenue growth. The firm's consistent history of beating estimates and the performance of its peers set the stage for a closely watched announcement.
All eyes are on healthcare giant McKesson as it prepares to report fourth-quarter results. With a history of revenue misses and a slowing growth rate, analysts and investors are keen to see if the company can deliver a positive surprise.
Globe Life (NYSE: GL) is set to report its fourth-quarter earnings after the market closes on Wednesday. With the insurance sector facing headwinds, investors are watching to see if the company can deliver growth that outpaces its recent history of revenue misses.
Fox Corporation (NASDAQ: FOXA) is scheduled to release its fourth-quarter financial results Wednesday morning, with analysts anticipating steady revenue but slower growth compared to last year's surge.
Medical device giant Boston Scientific (BSX) is scheduled to release its fourth-quarter financial results before market open on Wednesday, with Wall Street anticipating continued strong revenue growth and another potential earnings beat.
While EcoFirst Consolidated Bhd (KLSE:ECOFIRS) reported statutory profits, a deeper dive into its cash flow and earnings composition reveals underlying concerns that may have been overlooked by the market's muted reaction.
Food distribution leader Performance Food Group (NYSE: PFGC) is scheduled to release its quarterly earnings before markets open on Wednesday, with analysts projecting moderated revenue growth and continued pressure on profitability.
Central Garden & Pet (CENT) is scheduled to release its fourth-quarter financial results after Wednesday's market close, with Wall Street anticipating a year-over-year revenue decline. The report comes as the broader household products sector shows investor optimism.
CDW Corporation is set to report its fourth-quarter earnings before the market opens on Wednesday. Analysts project modest revenue growth, but the company's recent performance and broader sector trends suggest a cautious outlook.
Industrial manufacturer IDEX (IEX) is set to release its quarterly results Wednesday morning, with Wall Street anticipating a slight revenue increase. The report comes amid a broader rally in fluid and gas handling stocks.
Beyond the headlines of cash burn and production woes, Rivian Automotive is executing a strategic pivot. With falling costs, the imminent launch of its mass-market R2, and a growing software revenue stream, the company is laying the groundwork to transform from a pure EV manufacturer into a vertically integrated autonomy platform.
Twist Bioscience's proprietary silicon-based DNA manufacturing platform is driving double-digit revenue growth and margin expansion, positioning the synthetic biology tools provider on a clear path to adjusted EBITDA breakeven by fiscal 2026.
New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.
Despite a significant stock pullback following its transformative $4.1 billion acquisition of Paycor, Paychex (PAYX) presents a compelling case for patient investors. This analysis explores the strategic rationale behind the deal, near-term integration pressures, and the long-term defensive appeal of its recurring-revenue model in a volatile market for small-business services.
Brazil's state-controlled oil giant Petrobras is trading at deep value multiples, offering investors a covered dividend yield near 10%. Analysts argue its disciplined payout and exposure to a tightening global oil market create a rare mix of income and asymmetric upside.
ASGN Inc. is set to report its fourth-quarter financial results after the bell on Wednesday, with Wall Street anticipating another year-over-year revenue decline. Investors will scrutinize the performance for signs of stabilization in a competitive sector.
Homeland Security Secretary Kristi Noem will testify before House and Senate committees in March, as lawmakers probe the administration's immigration enforcement tactics following the fatal shootings of two U.S. citizens in Minnesota.
A Los Angeles family is mourning the devastating loss of Regan Cole-Graham, 36, and her unborn daughter after a cycling accident. The mother of two was riding with her family when she was struck by a vehicle.
Amid a competitive waste management sector, Waste Connections (WCN) is drawing investor attention for its focus on underserved rural markets and a vast network of landfills that create high barriers to entry. With a recent analysis pointing to significant upside potential, we examine the company's operational leverage, revenue diversification, and the financial metrics underpinning the bullish thesis.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
